605016.SS SHH
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
1W: +3.2%
1M: -0.4%
3M: -18.1%
YTD: -15.3%
1Y: +4.3%
3Y: +50.9%
5Y: +112.2%
¥21.11 ($3.15)
+0.38 (+1.83%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$301M
+54.6% ▲
5Y CAGR: +36.3%
Capital Expenditures
$282M
+9.7% ▲
5Y CAGR: +37.9%
Free Cash Flow
$19M
+116.3% ▲
5Y CAGR: +20.2%
Dividends Paid
$78M
-141.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$57M
+189.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $96M | $104M | $151M | $193M | $246M |
| Depreciation & Amort. | $43M | $47M | $47M | $46M | $77M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$22M | -$56M | -$49M | -$48M | -$23M |
| Other Non-Cash Items | $5M | $665K | $287K | $3M | $1M |
| Operating Cash Flow | $122M | $96M | $150M | $195M | $301M |
| — Investing Activities — | |||||
| Capital Expenditures | -$59M | -$56M | -$176M | -$312M | -$282M |
| Acquisitions (Net) | $52K | $19K | $1M | $0 | $0 |
| Investment Purchases | -$52K | -$345M | -$812M | -$630M | -$766M |
| Investment Sales | $3M | $103M | $739M | $710M | $875M |
| Other Investing | $18M | -$231K | $96K | $8M | $232K |
| Investing Cash Flow | -$38M | -$298M | -$247M | -$224M | -$173M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$50M | -$1M | $0 | $10M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$4M | -$1M | -$11M | -$32M | -$78M |
| Other Financing | -$1M | $412M | -$1M | -$2M | -$2M |
| Financing Cash Flow | -$9M | $362M | -$13M | -$34M | -$70M |
| Net Change in Cash | $75M | $161M | -$110M | -$63M | $57M |
| Cash End of Period | $130M | $291M | $181M | $118M | $174M |
| Free Cash Flow | $63M | $40M | -$26M | -$117M | $19M |